Share on LinkedInShare on LinkedIn

ARTICLE · 21 DECEMBER 2018

PAAB Gets Real

This update is intended for drug companies who market their products to healthcare professionals.

CanadaMedia, Telecoms, IT, Entertainment

PAAB is proposing to expand the types of evidence eligible for supporting advertising claims related to healthcare products. 

Currently, the PAAB Code of Advertising Acceptance (Code) requires that clinical or therapeutic claims in the advertising and promotion of health care products be limited to claims based on published, peer-reviewed, controlled and well-designed clinical studies of specific patient populations, such as randomized controlled clinical trials (RCTs). To a lesser extent, high quality meta-analysis and observational studies may sometimes be acceptable.

PAAB is now proposing to amend the Code to permit advertising claims based on an expanded definition of clinical data, to include data that is not derived from RCTs. 

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from